rs7911700

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017433.5(MYO3A):​c.508+180G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 152,056 control chromosomes in the GnomAD database, including 7,718 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 7718 hom., cov: 32)

Consequence

MYO3A
NM_017433.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.110

Publications

1 publications found
Variant links:
Genes affected
MYO3A (HGNC:7601): (myosin IIIA) The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]
MYO3A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 30
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal dominant 90
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 10-25997438-G-A is Benign according to our data. Variant chr10-25997438-G-A is described in ClinVar as Benign. ClinVar VariationId is 1250751.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.42 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO3ANM_017433.5 linkc.508+180G>A intron_variant Intron 6 of 34 ENST00000642920.2 NP_059129.3 Q8NEV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO3AENST00000642920.2 linkc.508+180G>A intron_variant Intron 6 of 34 NM_017433.5 ENSP00000495965.1 Q8NEV4-1

Frequencies

GnomAD3 genomes
AF:
0.307
AC:
46597
AN:
151936
Hom.:
7721
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.184
Gnomad AMI
AF:
0.238
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.266
Gnomad SAS
AF:
0.437
Gnomad FIN
AF:
0.395
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.323
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.306
AC:
46588
AN:
152056
Hom.:
7718
Cov.:
32
AF XY:
0.308
AC XY:
22922
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.183
AC:
7597
AN:
41474
American (AMR)
AF:
0.262
AC:
4003
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1337
AN:
3470
East Asian (EAS)
AF:
0.267
AC:
1385
AN:
5190
South Asian (SAS)
AF:
0.436
AC:
2100
AN:
4818
European-Finnish (FIN)
AF:
0.395
AC:
4162
AN:
10550
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24970
AN:
67948
Other (OTH)
AF:
0.324
AC:
685
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1621
3242
4862
6483
8104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.339
Hom.:
1213
Bravo
AF:
0.283
Asia WGS
AF:
0.339
AC:
1177
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.6
DANN
Benign
0.77
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7911700; hg19: chr10-26286367; API